Levemir (insulin detemir) has a shorter duration of action than other long-acting basal insulins like Sanofi's Lantus (insulin glargine) and biosimilars and Novo Nordisk's newer product Tresiba ...

Brandicourt's restructuring comes at a time when the company is facing some key challenges in its diabetes franchise, including headwinds for $7 billion-a-year insulin product Lantus (insulin ...

At present no reports on glulisine use in pregnancy are available. [53] Insulin Glargine. The first long-acting insulin analogue was approved for clinical use in patients with Type 1 and Type 2 ...

28 days Prescribing information Insulin glargine (rDNA origin) vial or cartridge Lantus vial or cartridge (Sanofi-Aventis) 28 days Prescribing information 70% insulin aspart protamine suspension ...

The FTC filed a lawsuit in September, accusing the three major PBMs of anticompetitive rebating practices related to insulin.